{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:25:27Z","timestamp":1772051127252,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"44-46","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.vaccine.2006.05.101","type":"journal-article","created":{"date-parts":[[2006,6,19]],"date-time":"2006-06-19T13:44:00Z","timestamp":1150724640000},"page":"6742-6746","source":"Crossref","is-referenced-by-count":28,"title":["Scientific lessons from the first influenza pandemic of the 20th century"],"prefix":"10.1016","volume":"24","author":[{"given":"J.S.","family":"Oxford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lambkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sefton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.05.101_bib1","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/jm980162u","article-title":"Structure activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors","volume":"41","author":"Kim","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.vaccine.2006.05.101_bib2","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomised controlled trial. U.S. Oral Neuraminidase Study Group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.05.101_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2006.05.101_bib4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.05.101_bib5","first-page":"148","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication","volume":"363","author":"Von Izstein","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2006.05.101_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor in the treatment of influenza virus infection","volume":"337","author":"Hayden","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.05.101_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/314904","article-title":"Efficacy and the safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections","volume":"180","author":"Monto","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.05.101_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/jinf.1999.0602","article-title":"Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomised double-blind, placebo-controlled European study","volume":"40","author":"Makela","year":"2000","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2006.05.101_bib9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-ada mantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.05.101_bib10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(69)90639-4","article-title":"Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study","volume":"2","author":"Galbraith","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.05.101_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(98)01182-9","article-title":"Clinical features and rapid diagnosis of human disease associated with avian influenza A H5N1 virus","volume":"351","author":"Yuen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.05.101_bib12","volume":"vols. 1 and 2","author":"Churchill","year":"1933"},{"key":"10.1016\/j.vaccine.2006.05.101_bib13","doi-asserted-by":"crossref","unstructured":"Phillips H, Killingray D. The Spanish influenza pandemic of 1918\u20131919: new perspectives. Routledge social history of medicine series; 2002.","DOI":"10.4324\/9780203468371"},{"key":"10.1016\/j.vaccine.2006.05.101_bib14","series-title":"America's forgotten pandemic","author":"Crosby","year":"1989"},{"key":"10.1016\/j.vaccine.2006.05.101_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(01)22115-1","article-title":"A further investigation into influenza pneumococcal and influenza\u2013streptococcal septicaemia and epidemic pneumonia of highly fatal type and its relation to purulent bronchitis","volume":"1","author":"Abrahams","year":"1919","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.05.101_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(01)52169-8","article-title":"Purulent bronchitis, its influenza and pneumococcal bacteriology","volume":"2","author":"Abrahams","year":"1917","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.05.101_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(01)56229-7","article-title":"Purulent bronchitis: a study of cases occurring amongst the British troops at a base in France","volume":"2","author":"Hammond","year":"1917","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.05.101_bib18","series-title":"Testament of youth","author":"Brittain","year":"1989"},{"key":"10.1016\/j.vaccine.2006.05.101_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nature04230","volume":"437","author":"Taubenberger","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2006.05.101_bib20","series-title":"Proceedings of the second European Congress on influenza","article-title":"Epidemiological evidence for cohort-specific immunological memory as a cause of increased mortality risk in the 1918 influenza pandemic","author":"Oeppen","year":"2005"},{"key":"10.1016\/j.vaccine.2006.05.101_bib21","unstructured":"Medical research committee. Special report series no. 36. Studies of influenza in hospitals of the British armies in France. London: HM Stationary Office; 1919."},{"key":"10.1016\/j.vaccine.2006.05.101_bib22","unstructured":"Report on the pandemic of influenza 1918\u20131919. Reports on the public health and medical subjects, no. 4. London: H.M. Stationary Office; 1920."},{"key":"10.1016\/j.vaccine.2006.05.101_bib23","series-title":"Human virology: a text for students of medicine","author":"Collier","year":"2006"},{"key":"10.1016\/j.vaccine.2006.05.101_bib24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3201\/eid0910.020789","article-title":"Influenza pandemic caused by highly conserved viruses with two receptor-binding variants","volume":"9","author":"Reid","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2006.05.101_bib25","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1126\/science.1093373","article-title":"Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus","volume":"303","author":"Stevens","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.05.101_bib26","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1126\/science.1093155","article-title":"The structure and receptor binding properties of the 1918 influenza hemagglutinin","volume":"303","author":"Gamblin","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.05.101_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.1119392","article-title":"Characterisation of the re-constructed 1918 Spanish influenza pandemic virus","author":"Tumpey","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.05.101_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature03063","article-title":"Transmissibility of 1918 pandemic influenza","volume":"432","author":"Mills","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2006.05.101_bib29","unstructured":"Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (in press)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06006293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06006293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T12:21:05Z","timestamp":1555676465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06006293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":29,"journal-issue":{"issue":"44-46","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0264410X06006293"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.05.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}